Yungjin Pharm Co Ltd Capital Reinvestment Ratio
Yungjin Pharm Co Ltd capital reinvestment ratio. Yungjin Pharm Co Ltd (003520) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.00 Billion) in capital expenditures (₩2.16 Billion). Check total reinvestment intensity of Yungjin Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Yungjin Pharm Co Ltd (2013–2024)
Capital reinvestment ratio of Yungjin Pharm Co Ltd from 2013 to 2024. This chart tracks Yungjin Pharm Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset growth rate of Yungjin Pharm Co Ltd to track the company's year-over-year net asset growth rate.
Yungjin Pharm Co Ltd Capital Reinvestment Ratio by Year (2013–2024)
Yungjin Pharm Co Ltd capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see Yungjin Pharm Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | ₩21.74 Billion | ₩21.61 Billion | ▼ -26.5% |
| 2021 | 1.35x | ₩8.37 Billion | ₩11.32 Billion | ▲ +211.1% |
| 2020 | 0.43x | ₩14.50 Billion | ₩6.30 Billion | ▼ -61.0% |
| 2019 | 1.12x | ₩9.28 Billion | ₩10.36 Billion | ▼ -69.8% |
| 2018 | 3.69x | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.9% |
| 2017 | 3.36x | ₩3.15 Billion | ₩10.59 Billion | ▲ +122.8% |
| 2016 | 1.51x | ₩3.11 Billion | ₩4.69 Billion | ▼ -3.5% |
| 2015 | 1.56x | ₩8.80 Billion | ₩13.75 Billion | ▼ -14.1% |
| 2014 | 1.82x | ₩6.22 Billion | ₩11.30 Billion | ▲ +63.3% |
| 2013 | 1.11x | ₩5.95 Billion | ₩6.63 Billion | — |